Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Pitman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Internal Medicine Journal|January 10, 2018
Towards a cure for human immunodeficiency virusMatthew C Pitman, Sharon R Lewin
Nature Immunology|July 17, 2019
CD4<sup>+</sup> T cell signatures in HIV infectionCeline Gubser, Matthew C Pitman, Sharon R Lewin
Critical Care Medicine|September 25, 2013
Eosinophils in severe sepsis in northern australia: do the usual rules apply in the tropics?Matthew C Pitman, Nicholas M Anstey, Joshua S Davis
The Lancet. HIV|June 13, 2018
Barriers and strategies to achieve a cure for HIVMatthew C Pitman, Jillian S Y Lau, James H McMahon, et al.
Plos Neglected Tropical Diseases|March 27, 2015
Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigmMatthew C Pitman, Tara Luck, Catherine S Marshall, et al.
Journal of Clinical Microbiology|January 31, 2014
Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rareDerek S Sarovich, Linda Ward, Erin P Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 3, 2018
Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomalleiDerek S Sarovich, Jessica R Webb, Matthew C Pitman, et al.
International Journal of Antimicrobial Agents|February 25, 2015
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New ZealandBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countriesBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of Virus Eradication|September 27, 2023
Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trialMatthew C Pitman, Niamh Meagher, David J Price, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Internal Medicine Journal|January 10, 2018
Towards a cure for human immunodeficiency virusMatthew C Pitman, Sharon R Lewin
Nature Immunology|July 17, 2019
CD4<sup>+</sup> T cell signatures in HIV infectionCeline Gubser, Matthew C Pitman, Sharon R Lewin
Critical Care Medicine|September 25, 2013
Eosinophils in severe sepsis in northern australia: do the usual rules apply in the tropics?Matthew C Pitman, Nicholas M Anstey, Joshua S Davis
The Lancet. HIV|June 13, 2018
Barriers and strategies to achieve a cure for HIVMatthew C Pitman, Jillian S Y Lau, James H McMahon, et al.
Plos Neglected Tropical Diseases|March 27, 2015
Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigmMatthew C Pitman, Tara Luck, Catherine S Marshall, et al.
Journal of Clinical Microbiology|January 31, 2014
Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rareDerek S Sarovich, Linda Ward, Erin P Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 3, 2018
Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomalleiDerek S Sarovich, Jessica R Webb, Matthew C Pitman, et al.
International Journal of Antimicrobial Agents|February 25, 2015
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New ZealandBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countriesBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of Virus Eradication|September 27, 2023
Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trialMatthew C Pitman, Niamh Meagher, David J Price, et al.
Pageof 2